8400 The Health Network
Eran Ophir currently serves as Chief Scientific Officer and Senior Vice President of Research and Drug Discovery at Compugen, roles held since September 2015, following various leadership positions within the company. Additionally, Eran Ophir is a member of 8400 The Health Network since October 2022. Prior experience includes a postdoctoral research fellowship at the Ludwig Institute for Cancer Research, focusing on immunotherapy for ovarian cancer, and a Ph.D. in Immunology from the Weizmann Institute of Science, where research centered on adoptive T cell therapy. Earlier roles included research assistant positions at the Weizmann Institute and Tel Aviv University, contributing to immune-based therapies and bioinformatics software development. Eran Ophir holds a B.Sc. in Bioinformatics from Tel Aviv University.
This person is not in the org chart
This person is not in any teams
8400 The Health Network
On a mission to drive an Israeli economic growth engine in HealthTech and accelerate global cure, 8400 The Health Network is weaving a network of HealthTech ecosystem leaders, across silos and sectors, who learn together and create gap-closing projects that will propel a thriving HealthTech industry in Israel. The 8400 Fellowship runs annual cohorts of 60 senior Israeli leaders each, for an intensive 17 day program across 7 months. The program’s tailor-made curriculum is creating a continuous platform for breaking silos, peer learning and designing ecosystem growth initiatives. 8400 fellowship graduates join the 8400 Network.